IMMX
IMMX
NASDAQ · Biotechnology

Immix Biopharma Inc

$8.32
-0.23 (-2.69%)
As of Aug 8, 1:58 AM ET ·
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Buy 11 92%
Hold 1 8%
Sell 0 0%
Price Target
Analyst Price Target +44.0% upside
Low Target $7.05
Average Target $11.98
High Target $14.20
Current Price $8.32
Current
$8.32
Target
$11.98
$7.05 $11.98 avg $14.20
Scenario Analysis
Bear Case
$7.05
-15.3%
Low target
Base Case
$11.98
+44.0%
Avg target
Bull Case
$14.20
+70.7%
High target
Risk/Reward
4.6x
Highly favorable
Price in Context
52-Week High
$12.14
-31.5% from high
52-Week Low
$1.94
+328.9% from low
Target vs 52W High
$11.98
-1.3% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 79% $257.58 +4.7%
AMGN
Amgen Inc
Hold 43 49% $190.87 -53.6%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +172.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 40 83% $438.34 -11.6%
REGN
Regeneron Pharmaceuticals
Buy 38 71% $76.80 -90.2%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -55.6%
RVMD
Revolution Medicines Inc
Strong Buy 29 93% $114.11 -44.4%
BIIB
Biogen Inc
Buy 44 64% $91.45 -56.0%